| Authors: |
Pujana MA; ProCURE, Catalan Institute of Oncology, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Spain.; Precision Oncology in Girona (OncoGir), Girona Institute for Biomedical Research (IDIBGI), Girona, Spain., Brunet J; Precision Oncology in Girona (OncoGir), Girona Institute for Biomedical Research (IDIBGI), Girona, Spain.; Hereditary Cancer Program, Catalan Institute of Oncology, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Spain., Antoniou AC; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom. |